Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice
- 41 Downloads
The long term effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis in mice were tested under two different treatment protocols. A prophylactic experiment examined the effects of the daily drug administration for 180 days beginning one day before the first collagen injection. Under this dosage schedule, cyclophosphamide and cyclosporin decreased the severity of arthritis, while indomethacin did not. A therapeutic protocol examined the effects of these same drugs when daily administration was delayed until the animals had active disease at 78 days after the first collagen injection. Under this protocol, all three drugs reduced the progression of disease. In both protocols, the most significant suppression of arthritis was seen in animals receiving cyclophosphamide which was associated with a decrease in anti-collagen antibody levels. Collagen-induced arthritis in mice should be further investigated as a model to study the long term effects of “slow-acting” anti-rheumatic drugs.
KeywordsPlacebo Arthritis Cyclosporin Cyclophosphamide Indomethacin
Unable to display preview. Download preview PDF.
- M. Cremer,Type II collagen-induced arthritis in rats. InHandbook of Animal Models for the Rheumatic Disease. Volume 1 (Eds. R. A. Greenwald and H. S. Diamond) pp. 17–27, CRC Press, Boca Raton, Florida 1988.Google Scholar
- M. M. Griffiths, E. J. Eichwald, J. H. Martin, C. B. Smith and C. W. DeWitt,Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arth. Rheum.24, 781–789 (1981).Google Scholar
- M. M. Griffiths and C. W. DeWitt,Immunogenetic control of experimental collagen-induced arthritis in rats. II. ECIA susceptibility and immune response to type II collagen (calf) are linked to RT1. J. Immunogen.8, 463–470 (1981).Google Scholar
- J. S. Garvey, N. E. Cremer and D. H. Sussdorf,Methods in Immunology: a lab text for instruction and research. (3rd edition) pp. 301–312, The Benjamin cummings Publishing Company, Reading, MA, 1977.Google Scholar
- C. Rordorf, A. Pataki, V. Nogues, F. Schlager, U. Feige and M. Glatt,Arthritis in MRL/lpr mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Int. J. Tiss.9, 341–347 (1987).Google Scholar
- A. E. Sloboda, J. E. Birnbaum, A. L. Oronsky and S. S. Kerwar,Studies on type II collagen-induced polyarthritis in rats. Effects of anti-inflammatory and anti-rheumatic agents. Arthritis and Rheum.24, 616–624 (1981).Google Scholar
- A. W. Probert Jr., D. J. Schrier and R. B. Gilbertsen,Effects of Antiarthritic compounds on type II collagen-induced arthritis in rats. Arch. Int. Pharm.269, 167–176 (1984).Google Scholar
- N. Seki, Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh and H. Fujiwara,Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol.140, 1477–1484 (1988).PubMedGoogle Scholar
- R. Holmdahl, L. Klareskog, K. Rubin, E. Larsson and H. Wigzell,T-Lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scan. J. Immun.22, 295–306 (1985).Google Scholar
- P. H. Wooley, H. S. Luthra, C. H. Krco, J. M. Stuart and C. S. David,Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of antitype II collagen antibody or free native type II collagen.Arthritis and Rheum. 27, 1010–1017 (1984).Google Scholar
- J. M. Stuart, L. K. Myers, A. S. Townes and A. H. Kang,Effect of cyclophosphamide, hydrocortisone, and levamisole on collagen-induced arthritis in rats. Arthritis and Rheum.24, 790–794 (1981).Google Scholar